Gelonghui, March 18 | Hualing Pharmaceutical-B (02552.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve, including the Group's annual results for the year ended December 31, 2023, and the proposed final dividend (if any), and other matters.
华领医药-B(02552.HK)3月28日举行董事会会议考虑及通过全年业绩
Hualing Pharmaceutical-B (02552.HK) held a board meeting on March 28 to consider and approve the annual results
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.